BeOne Medicines (ONC) EBITDA Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | -2,649.00 |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 30,461.00 |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | 2,139.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,261.00 |
| Mar 31, 2026 | 9,942.00 |
| Dec 31, 2025 | 13,564.00 |
| Sep 30, 2025 | 12,464.00 |
| Jun 30, 2025 | 13,532.00 |
| Mar 31, 2025 | 14,556.00 |
| Dec 31, 2024 | 26,015.00 |
| Sep 30, 2024 | 21,194.00 |
| Jun 30, 2024 | 30,504.00 |
| Mar 31, 2024 | -4,635.00 |
| Dec 31, 2023 | 42,393.00 |
| Sep 30, 2023 | 46,610.00 |
| Jun 30, 2023 | 49,323.00 |
| Mar 31, 2023 | 63,504.00 |
| Dec 31, 2022 | 55,877.00 |
| Sep 30, 2022 | 50,969.00 |
| Jun 30, 2022 | -9,337.00 |
| Mar 31, 2022 | 7,867.00 |
| Dec 31, 2021 | 21,143.00 |
| Sep 30, 2021 | 5,482.00 |